Skip to main content
Clinical Trials/ChiCTR1900021028
ChiCTR1900021028Not yet recruitingEarly Phase 1

超声引导新入路髂筋膜间隙阻滞药物扩散:10 例健康志愿者的 MRI 评估.

福建省立医院科研基金1 site in 1 country10 target enrollmentStarted: March 1, 2019Last updated:

Trial Snapshot

Phase
Early Phase 1
Status
Not yet recruiting
Sponsor
Enrollment
10
Locations
1
Primary Endpoint
药液扩散范围

Study Overview

Brief Summary

本试验利用 MRI 技术观察超声引导下新入路髂筋膜间隙阻滞的局麻药扩散情况,为临床推广新入路 UGFICB 提供理论依据。

Study Design

Study Type
观察性研究
Primary Purpose
病例研究
Masking

Eligibility Criteria

Ages
18 to 75 (—)
Sex
All

Inclusion Criteria

  • 心肺功能良好,无服用抗凝药物;
  • 知情同意并自愿参加该项研究。

Exclusion Criteria

  • 无法或拒绝签署知情同意书者。

Arms & Interventions

新入路组

超声引导下改良入路髂筋膜间隙注入局麻药,MRI 观察药液扩散情况。

Outcomes

Primary Outcomes

药液扩散范围

Time Frame: FICB 完成 15min 后

大腿外侧感觉阻滞

Time Frame: 注药后 45min

大腿前侧感觉阻滞

Time Frame: 注药后 45min

大腿内侧感觉阻滞

Time Frame: 注药后 45min

股神经运动阻滞

Time Frame: 注药后 45min

闭孔神经运动阻滞

Time Frame: 注药后 45min

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
福建省立医院科研基金

Study Sites (1)

Loading locations...

Similar Trials